Celecoxibdrug info
celecoxib 200 MG Oral Capsule [Celebrex]
What it is used for
CELEBREX is indicated CELEBREX is a nonsteroidal anti-inflammatory drug indicated for:
Osteoarthritis (OA)
Rheumatoid Arthritis (RA)
Juvenile Rheumatoid Arthritis (JRA) in patients 2 years and older
Ankylosing Spondylitis (AS)
Acute Pain (AP)
Primary Dysmenorrhea (PD)
1.1 Osteoarthritis (OA)
For the management of the signs and symptoms of OA.
1.2 Rheumatoid
Arthritis (RA) For the management of the signs and symptoms of RA.
1.3 Juvenile
Rheumatoid Arthritis (JRA) For the management of the signs and symptoms of JRA in patients 2 years and older.
1.4 Ankylosing
Spondylitis (AS) For the management of the signs and symptoms of AS.
1.5 Acute Pain
For the management of acute pain in adults.
1.6 Primary
Dysmenorrhea For the management of primary dysmenorrhea.
Text above is quoted in full from the FDA-approved drug label published by openFDA, effective November 22, 2024. Matched to this product by RxNorm code. Cross-references to other sections of the full prescribing information have been removed, since they point to a document not shown here. Nothing else is changed: no sentence is shortened, reworded or summarised.
Description
CELEBREX (celecoxib) capsule is a nonsteroidal anti-inflammatory drug, available as capsules containing 50 mg, 100 mg, 200 mg and 400 mg celecoxib for oral administration. The chemical name is 4-[5-(4-methylphenyl)- 3-(trifluoromethyl)-1H-pyrazol-1-yl] benzenesulfonamide and is a diaryl-substituted pyrazole. The molecular weight is 381.38. Its molecular formula is C 17 H 14 F 3 N 3 O 2 S, and it has the following chemical structure: Celecoxib is a white to off-white powder with a pKa of 11.1 (sulfonamide moiety). Celecoxib is hydrophobic (log P is 3.5) and is practically insoluble in aqueous media at physiological pH range. The inactive ingredients in CELEBREX include: croscarmellose sodium, edible inks, gelatin, lactose monohydrate, magnesium stearate, povidone and sodium lauryl sulfate. chemical structure
Text above is quoted in full from the FDA-approved drug label published by openFDA, effective November 22, 2024. Matched to this product by RxNorm code. Cross-references to other sections of the full prescribing information have been removed, since they point to a document not shown here. Nothing else is changed: no sentence is shortened, reworded or summarised.
This page reproduces regulatory text for reference. It is not medical advice, and KenyRx is not a pharmacy or a prescriber. Talk to a doctor or pharmacist about whether a medicine is right for you.
See what it costs — price without insurance